Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | BLM | P54132 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | CASP7 | P55210 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | PABPC1 | P11940 | 1/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 0.64 |
| ▸ | POLB | P06746 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | PKM | P14618 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | PDE3B | Q13370 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alloxazine SCHEMBL29516835 | 1.00 | KDM4E (1.00) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| Alloxazine SCHEMBL9619177 | 0.98 | KDM4E (0.96) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| Alloxazine SCHEMBL8745680 | 0.90 | BLM (0.81) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL23908716 | 0.87 | KDM4E (0.77) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL14493337 | 0.83 | BLM (0.70) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL11087373 | 0.83 | KDM4E (0.69) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL16740699 | 0.80 | BLM (0.66) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL11405850 | 0.80 | KDM4E (0.66) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL498444 | 0.80 | TDP1 (0.66) | KDM4EBLMTDP1ALDH1A1CASP7 | |
| SCHEMBL498704 | 0.80 | BLM (0.66) | KDM4EBLMTDP1ALDH1A1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1966 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107412-A1 | SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122051299-A | Method for recovering capacity of water system organic flow battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | claimed |
| US-20260034277-A1 | SYSTEMS AND METHODS FOR PATHOGEN INACTIVATION OF BLOOD PRODUCTS | CERUS CORP (US) | 2026-02-05 | — | — | US | claimed |
| US-20250372657-A1 | HIGH ENERGY DENSITY GEL ELECTRODES AND METHOD OF MAKING AND USING THE SAME | BATTELLE MEMORIAL INSTITUTE (US) | 2025-12-04 | — | — | US | claimed |
| US-12364949-B2 | Method for electrochemical gas separation | VERDOX, INC. (US) | 2025-07-22 | — | — | US | claimed |
| US-20250230075-A1 | ELECTROCHEMICAL ION EXTRACTION APPARATUS AND METHOD OF USE | UNIVERSITY OF SOUTH CAROLINA | 2025-07-17 | — | — | US | claimed |
| EP-3976197-B1 | THERAPEUTICS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER | LUNELLA BIOTECH INC (CA) | 2025-07-16 | — | — | EP | claimed |
| US-20250219113-A1 | A METAL-FEEDING METHOD FOR METAL-AIR FUEL CELLS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-07-03 | — | — | US | claimed |
| US-20250219121-A1 | A METAL ELECTRODE SYSTEM FOR ELECTROCHEMICAL CELLS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-07-03 | — | — | US | claimed |
| EP-3934594-B1 | ENERGY AUGMENTATION STRUCTURES FOR USE IN NON-INVASIVE IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT LLC (US) | 2025-05-28 | — | — | EP | claimed |
| WO-1995011028-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1995-04-27 | — | — | WO | claimed |
| EP-0384366-B1 | Photosensitive recording element | BASF AG (DE) | 1995-02-15 | — | — | EP | claimed |
| US-5126247-A | For enzymatic colorimatic measurement of presence or concentration of analytes in samples of animal fluids; medical diagnosis | ENZYMATICS, INC. (US) | 1992-06-30 | — | — | US | claimed |
| US-5112723-A | Relief images, printing plates, photoresists, alloxazine compounds | BASF AKTIENGESELLSCHAFT (DE) | 1992-05-12 | — | — | US | claimed |
| EP-0384366-A2 | Photosensitive recording element | BASF Aktiengesellschaft (DE) | 1990-08-29 | — | — | EP | claimed |
| EP-0330517-A2 | Method, system and devices for the assay and detection of biochemical molecules | SOLARCARE TECHNOLOGIES CORPORATION (US) | 1989-08-30 | — | — | EP | claimed |
| EP-0105382-B1 | IMAGE-FORMING PHOTO-SENSITIVE MATERIAL | SONY CORPORATION (JP) | 1987-01-07 | — | — | EP | claimed |
| US-4496646-A | Photosensitive imaging material | SONY CORPORATION (JP) | 1985-01-29 | — | — | US | claimed |
| EP-0105382-A1 | IMAGE-FORMING PHOTO-SENSITIVE MATERIAL | SONY CORPORATION (JP) | 1984-04-18 | — | — | EP | claimed |
| US-4094687-A | A DIIMINOPIPERAZINE-ALDEHYDE CONDENSATION PRODUCT AND CYCLIC POLYKETO COMPOUND | GRAPHIC CONTROLS CORPORATION | 1978-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034277-A1 | SYSTEMS AND METHODS FOR PATHOGEN INACTIVATION OF BLOOD PRODUCTS | PRF1, CFD, F5 | KDM4E 4393/4885BLM 3156/4885TDP1 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.